Mylan independence from Teva's embrace comes with a price
July 27, 2015 at 18:11 PM EDT
July 27 (Reuters) - Generic drugmaker Mylan NV won a reprieve on Monday from its unwanted suitor, Teva Pharmaceutical Industries, but now faces an uphill battle to make its own acquisition as its biggest rival just got bigger.